Scientific Programme (Detailed)

Registration

Sunrise Session

Opening Remarks

Presidential Lecture

• Antibody treatment in asthma
  – Elisabeth Bel (Netherlands)
• Anti-neutrophil treatment in asthma
  – Peter Barnes (UK)
• Bronchial thermoplasty in asthma
  – Gerard Cox (Canada)

• CT for infectious lung diseases
  – Abdul Samad Sakijan (Malaysia)
• CT for COPD
  – Nguyen Van Tho (Vietnam)
• CT for rare lung diseases
  – Masashi Takahashi (Japan)

• Recent progress of cellular and molecular biology in respiratory diseases
  – Takahide Nagase (Japan)
• Generation of airway epithelial cells from iPS cells
  – Isao Ito (Japan)
• Role of microbiomes in lung diseases
  – Philips Hansbro (Australia)

Concurrent Session 2A: COPD

• Non-smoking COPD versus neutrophilic asthma: similarities and differences
  – Jorgen Vestbo (UK)
• Asthma-COPD overlap syndrome: biomarker, phenotype or endotype-driven treatment
  – Diahn-Warng Perng (Taiwan)
• Steroid insensitivity and target therapy for COPD: What do we need and where are we now?
  – Peter Barnes (UK)

Concurrent Session 2B: Clinical Respiratory Medicine 1

• Case 1
  – Abdul Razak Muttalif (Malaysia)
• Case 2
  – Sanjeev K. Mehta (India) 
• Case 3
  – Sanjay H. Chotirmall (Singapore)  

Concurrent Session 2C: Environmental & Occupational Health & Epidemiology

• E-cigarettes - The good, the bad and the ugly
  – Hayden McRobbie (New Zealand)
• Asbestos ban and asbestos-related diseases in Asia
  – Soon-Hee Jung (Korea)
• Effect of inorganic dust on the lung
  – Takashi Nakano (Japan)

Heritage meets Innovation in the Management of COPD
(Sponsored by: Boehringer Ingelheim)

– Lim Seong Yong
– Peter MA Calverly

Bronchodilators - A breath of fresh air into the current thinking for COPD
(Sponsored by: Novartis)

– Diahn-Warng Perng
– Klaus Rabe
– Christine Jenkins

Populations to patients : Personalised medicine in COPD (Sponsored by: GlaxoSmithKline Pharmaceutical)

– Kourtney Davis
– Paul Jones
– Chris Lai

Concurrent Session 3A: Lung Cancer 1

• What’s new in the next revision of lung cancer staging
  – Kwun Fong (Australia)
• Molecular testing in advanced NSCLC
  – David Chi Leung Lam (Hong Kong)
• Management of resistance to EGFR-TKIs and ALK-inhibitors
  – Chong-Kin Liam (Malaysia)

Concurrent Session 3B: Respiratory Infection (non-TB)

• Pulmonary aspergillosis
  – Sanjay H. Chotirmall (Singapore)
• Antibiotic resistance in pneumonia- Asia Pacific perspective
  – Yuan-Lin Song (China) 
• Pulmonary melioidosis
  – Soon-Hin How (Malaysia)

Concurrent Session 3C: Respiratory Neurobiology and Sleep 1

• OSA and COPD (Overlap syndrome) in Asians and Western countries
  – Patrick Gerard Moral (Philippines)
• Obesity hypoventilation syndromes in Asians and Western countries
  – Kazuo Chin (Japan)
• Recent advances inOSA and sleep Medicine
  – Atul Malhotra (USA) 

Coffee Break

Concurrent Session 4A: Lung cancer 2

• Evolving role of immunotherapy for NSCLC
  – Ross Andrew Soo (Singapore)
• Small cell lung cancer: the evolving role of radiotherapy
  – Yoichi Nakanishi (Japan)
• Update on Asian lung cancer screening: randomised and non-randomised studies
  – David Chi Leung Lam (Hong Kong)

Concurrent Session 4B: Interstitial Lung Disease 1

• Difficult-to-diagnose interstitial lung disease: the role of the multidisciplinary team
  – John Simpson (UK)
• The role of CT scan in interstitial lung diseases
  – Masashi Takahashi (Japan)
• Advances in the treatment of IPF
  – Takashi Ogura (Japan)

Concurrent Session 4C: Pleural Diseases

• Unusual pleural diseases
  – Anantham Devanand (Singapore)
• Management of complicated parapneumonic effusion and empyema thoracis
  – Pyng Lee (Singapore)
• Current management of malignant mesothelioma
  – Agasthian Thirugnanam (Singapore)

New perspectives for mucoactive drugs in COPD treatment: The RESTORE study (Sponsored by Recipharm / Edmond Pharma)

– Roberto W Dal Negro

Asthma and COPD Overlap Syndrome (ACOS) – An India Perspective (Sponsored by: Cipla Malaysia Sdn Bhd / Cipla Limited)

– Harjit Dumra

Faculty Dinner (By Invitation only)

Registration

Sunrise Session

Memorial Lecture: Michiyoshi Harasawa Research Award

Concurrent Session 5A: Respiratory Neurobiology and Sleep 2

• The upper airway function in OSA
  – Peter Eastwood (Australia)
• Relationship between OSA and gastroesophageal reflux
  – Patrick Gerard Moral (Philippines) 
• Cerebro-cardiovascular diseases in the Korean OSA cohort study
  – Chol Shin (South Korea)

Concurrent Session 5B: Paediatric Lung Diseases 1

• Acute management of childhood asthma – an update
  – Albert Li (Hong Kong)
• Is intermittent use of inhaled corticosteroids a feasible option in children?
  – Anne Goh (Singapore) 
• Longer term outcome of childhood asthma – what do the longitudinal studies tell us
  – Peter Le Souef (Australia)

Concurrent Session 5C: Bronchoscopy & Interventional Pulmonology

• Bronchoscopic lung volume reduction: What’s the current status?
  – Lonny Yarmus (USA)
• Dealing with granulation tissue post stenting - Any solution?
  – Philip Eng (Singapore)
• Bronchoscopic management of tracheobronchomalacia / EDAC
  – Jamsak Tscheikuna (Thailand)

Coffee Break

Concurrent Session 6A: Asthma 2

• Identifying therapeutic phenotypes of severe asthma
  – Kittipong Maneechotesuwan (Thailand)
• What are the current and future treatment options for refractory asthma?
  – Omar Sharif Usmani (UK)
• Poorly controlled asthma in pregnancy: What can we use?
  – Dave Singh (UK)

Concurrent Session 6B: Paediatric Lung Diseases 2

• Update and controversies in the management of childhood pneumonia
  – Anne Chang (Australia)
• Viruses in paediatric respiratory disease
  – Peter Le Souef (Australia)
• Bronchiectasis: is it a reversible disease?
  – Anne Chang (Australia)

Concurrent Session 6C: Pulmonary circulation 1

• Screening and diagnosis of pulmonary hypertension
  – Aizai Azan Abd Rahim (Malaysia)
• Mechanism and management of hypoxia-induced pulmonary hypertension
  – Talant Sooronbaev (Kyrgyzstan)
• Novel therapy for acute pulmonary embolism
  – Heng-Joo Ng (Singapore)

Beyond ICS/LABA: The Role of Tiotropium Respimat in Asthma
(Sponsored by: Boehringer Ingelheim)

– Nicola Hanania
– Dina Diaz

Conversations in IgE-mediated severe asthma – Past, present and future
(Sponsored by Novartis)

– Tse-Wen Chang
– Jo Douglass
– David Price

The Key Role of Small Airways in Asthma and COPD
(Sponsored by Chiesi and Orient EuroPharma)

– Dave Singh
– Pang Yong Kek

Concurrent Session 7A: Young Investigator Session 2

Concurrent Session 7B: Clinical Allergy & Immunology

• Epithelial biology in the pathogenesis of airway inflammation
  – Yasuhiro Gon (Japan)
• Recent advances in the pathogenesis of asthma
  – Elisabeth Bel (Netherlands)
• The lung's response to air pollution
  – Ian Yang (Australia)

Concurrent Session 7C: Pulmonary circulation 2

• The journey to PAH and PH-related respiratory diseases
  – Hiroshi Kimura (Japan)
• Treatment update on CTEPH
  – Nobuhiro Tanabe (Japan)
• Treatment update on PAH
  – Masayuki Hanaoka (Japan)

Coffee Break

The Great Debate
Inhaled corticosteroids has a limited role in the management of COPD

Exploring the bronchial tree in asthma: Probing deep into the small airways 
(Sponsored by Mundipharma)

– Omar S Usmani
– Chul-Gyu Yoo

Treating the underlying inflammation to achieve asthma control
(Sponsored by AstraZeneca)

– Christine Jenkins

Gala Dinner

Registration

Sunrise Session

Memorial Lecture: Ann Janet Woolcock Research Award

Concurrent Session 8A: Tuberculosis 1

• TB in Asia Pacific
  – Nobuyuki Nishikiori (WHO West Pacific Region)
• Public-Private Mix in TB Control: Critical appraisal of global evidence and local applications
  – Charles Yu (Philippines)
• TB and migrants
  – Nobuyuki Nishikiori (WHO West Pacific Region)

Concurrent Session 8B: Respiratory Structure & Function

• Role of handheld spirometer in the screening, diagnosis and monitoring of airflow limitation
  – Le Thi Tuyet Lan (Vietnam)
• Diffusion capacity – pitfalls and interpretation
  – Peter Eastwood (Australia)
• Tips and tricks to achieve best lung deposition with different inhaler devices
  – Yuko Komase (Japan)

Concurrent Session 8C: Clinical Respiratory Medicine 2 (Late-breaker Session)

• Epidemiology and clinical data of MERS-CoV in South Korea
  – David Shu-Cheong Hui (Hong Kong)
• From SARS to MERS - lessons learned?
  – David Shu-Cheong Hui (Hong Kong)
• Emerging Infections:  How can we improve preparedness?
  – Leo Lit-Man Poon (Hong Kong)

Coffee Break

Idiopathic Pulmonary Fibrosis - Recent perspective and future challenges
(Sponsored by Boehringer Ingelheim)

– Ganesh Raghu
– Dong Soon Kim
– Ulrich Costabel

Pneumonia Prevention in Adults: Current Perspectives
(Sponsored by Pfizer)

– Rontgene Solante
– Abdul Razak Bin Abdul Muttalif

Concurrent Session 9A: Tuberculosis 2

• New TB diagnostic tests
  – Somsak Rienthong (Thailand)
• Challenges of MDR TB management
  – Harjit Dumra (India)
• Diagnosis and treatment dilemma of nontuberculous mycobacterial infection
  – Erlina Burhan (Indonesia)

Concurrent Session 9B: Interstitial Lung Diseases 2

• Prevalence and incidence of ILD in the Asia-Pacific region
  – Yoshikazu Inoue (Japan)
• Pathogenesis, diagnosis and treatment of co-existing emphysema and ILD
  – Masahito Ebina (Japan)
• The ABC of hypersensitivity pneumonitis - from the acute to chronic stages
  – Tengku Saifudin Tengku Ismail (Malaysia)

Concurrent Session 9C: Critical Care Medicine

• Diagnosis of ventilator-acquired pneumonia - difficult but do-able
  – John Simpson (UK)
• ECMO - Extracorporeal Membrane Oxygenation in ARDS
  – Yoshiki Ishii (Japan)
• Early mobilisation of the ventilated patient: evidence to practice
  – Li-Ling Tai (Malaysia)